Global cancer statistics, 2012
Lindsey A. Torre,Freddie Bray,Rebecca L. Siegel,Jacques Ferlay,Joannie Lortet-Tieulent,Ahmedin Jemal +5 more
Reads0
Chats0
TLDR
A substantial portion of cancer cases and deaths could be prevented by broadly applying effective prevention measures, such as tobacco control, vaccination, and the use of early detection tests.Abstract:
Cancer constitutes an enormous burden on society in more and less economically developed countries alike. The occurrence of cancer is increasing because of the growth and aging of the population, as well as an increasing prevalence of established risk factors such as smoking, overweight, physical inactivity, and changing reproductive patterns associated with urbanization and economic development. Based on GLOBOCAN estimates, about 14.1 million new cancer cases and 8.2 million deaths occurred in 2012 worldwide. Over the years, the burden has shifted to less developed countries, which currently account for about 57% of cases and 65% of cancer deaths worldwide. Lung cancer is the leading cause of cancer death among males in both more and less developed countries, and has surpassed breast cancer as the leading cause of cancer death among females in more developed countries; breast cancer remains the leading cause of cancer death among females in less developed countries. Other leading causes of cancer death in more developed countries include colorectal cancer among males and females and prostate cancer among males. In less developed countries, liver and stomach cancer among males and cervical cancer among females are also leading causes of cancer death. Although incidence rates for all cancers combined are nearly twice as high in more developed than in less developed countries in both males and females, mortality rates are only 8% to 15% higher in more developed countries. This disparity reflects regional differences in the mix of cancers, which is affected by risk factors and detection practices, and/or the availability of treatment. Risk factors associated with the leading causes of cancer death include tobacco use (lung, colorectal, stomach, and liver cancer), overweight/obesity and physical inactivity (breast and colorectal cancer), and infection (liver, stomach, and cervical cancer). A substantial portion of cancer cases and deaths could be prevented by broadly applying effective prevention measures, such as tobacco control, vaccination, and the use of early detection tests.read more
Citations
More filters
Journal ArticleDOI
Breast Cancer and Its Relationship with the Microbiota.
Mariana F. Fernández,Iris Reina-Pérez,Juan Manuel Astorga,Andrea Rodríguez-Carrillo,Julio Plaza-Díaz,Luis Fontana +5 more
TL;DR: Specific characteristics of the human microbiome are identified that may serve to develop novel approaches for risk assessment, prevention and treatment for this disease.
Journal ArticleDOI
Inhibition of Acetyl-CoA Carboxylase by Phosphorylation or the Inhibitor ND-654 Suppresses Lipogenesis and Hepatocellular Carcinoma
James S. V. Lally,Sarani Ghoshal,Danielle K. DePeralta,Omeed Moaven,Lan Wei,Ricard Masia,Derek J. Erstad,Naoto Fujiwara,Vivian Leong,Vanessa P. Houde,Alexander E. Anagnostopoulos,Alice Wang,Lindsay A. Broadfield,Rebecca J. Ford,Robert A. Foster,Jamie Bates,Hailing Sun,Ting Wang,Henry Liu,Adrian S. Ray,Asish K. Saha,Jeremy R. Greenwood,Sathesh Bhat,Geraldine Harriman,Wenyan Miao,Jennifer Rocnik,William F. Westlin,Paola Muti,Theodoros Tsakiridis,H. James Harwood,Rosana Kapeller,Yujin Hoshida,Kenneth K. Tanabe,Gregory R. Steinberg,Bryan C. Fuchs +34 more
TL;DR: A novel, liver-specific ACC inhibitor that mimics the effects of ACC phosphorylation inhibits hepatic DNL and the development of HCC, improving survival of tumor-bearing rats when used alone and in combination with the multi-kinase inhibitor sorafenib.
Journal ArticleDOI
Trial Design and Endpoints in Hepatocellular Carcinoma: AASLD Consensus Conference
Josep M. Llovet,Augusto Villanueva,Jorge A. Marrero,Myron Schwartz,Tim Meyer,Peter R. Galle,Riccardo Lencioni,Tim F. Greten,Masatoshi Kudo,Sumithra J. Mandrekar,Andrew X. Zhu,Richard S. Finn,Lewis R. Roberts +12 more
TL;DR: A framework to facilitate capturing the efficacy of novel therapeutic strategies with the goal of improving the outcomes of patients suffering from Hepatocellular carcinoma is articulate.
Journal ArticleDOI
Cancer and liver cirrhosis: implications on prognosis and management
TL;DR: This review provides a concise overview about the impact of liver cirrhosis on the management and prognosis of patients with primary liver cancer or non-hepatic malignancies.
Journal ArticleDOI
Single-Molecular Near-Infrared-II Theranostic Systems: Ultrastable Aggregation-Induced Emission Nanoparticles for Long-Term Tracing and Efficient Photothermal Therapy.
Nuernisha Alifu,Abudureheman Zebibula,Abudureheman Zebibula,Ji Qi,Hequn Zhang,Chaowei Sun,Xiaoming Yu,Dingwei Xue,Jacky Wing Yip Lam,Gonghui Li,Jun Qian,Jun Qian,Ben Zhong Tang,Ben Zhong Tang +13 more
TL;DR: A single-molecular and NIR-II-emissive theranostic system designed by encapsulating a kind of aggregation-induced emission luminogen (AIEgen, named BPN-BBTD) with amphiphilic polymer that holds potential for the diagnosis, precise treatment, and metastasis monitoring of tumors in the future.
References
More filters
Journal ArticleDOI
Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012.
Jacques Ferlay,Isabelle Soerjomataram,Rajesh Dikshit,Sultan Eser,Colin Mathers,Marise Souto Rebelo,Donald Maxwell Parkin,David Forman,Freddie Bray +8 more
TL;DR: The GLOBOCAN series of the International Agency for Research on Cancer (IARC) as mentioned in this paper provides estimates of the worldwide incidence and mortality from 27 major cancers and for all cancers combined for 2012.
Journal ArticleDOI
IARC Monographs on the Evaluation of Carcinogenic Risks to Humans
TL;DR: This timely monograph is a distillation of knowledge of hepatitis B, C and D, based on a review of 1000 studies by a small group of scientists, and it is concluded that hepatitis D virus cannot be classified as a human carcinogen.
Book
Cancer Incidence in Five Continents
Freddie Bray,J. Ferlay,Mathieu Laversanne,David H. Brewster,C. Gombe Mbalawa,B. Kohler,Marion Piñeros,Eva Steliarova-Foucher,Rajaraman Swaminathan,Sebastien Antoni,Isabelle Soerjomataram,David Forman +11 more
TL;DR: The aim of this study was to establish a database of histological groups and to provide a level of consistency and quality of data that could be applied in the design of future registries.
Journal ArticleDOI
Reduced lung-cancer mortality with low-dose computed tomographic screening.
Denise R. Aberle,Amanda M. Adams,Christine D. Berg,William C. Black,Jonathan D. Clapp,Richard M. Fagerstrom,Ilana F. Gareen,Constantine Gatsonis,Pamela M. Marcus,JoRean D. Sicks +9 more
TL;DR: Screening with the use of low-dose CT reduces mortality from lung cancer, as compared with the radiography group, and the rate of death from any cause was reduced.